ORAL CAVITY MUCOSAL MELANOMA

Clinical trials for ORAL CAVITY MUCOSAL MELANOMA explained in plain language.

Never miss a new study

Get alerted when new ORAL CAVITY MUCOSAL MELANOMA trials appear

Sign up with your email to follow new studies for ORAL CAVITY MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double attack on rare cancer: can new drug combo stop deadly Melanoma's return?

Disease control Recruiting now

This trial is for people with mucosal melanoma, a rare and aggressive cancer, that has been surgically removed. It tests whether adding a pill called cabozantinib to an immunotherapy drug (nivolumab) is better at preventing the cancer from returning than the immunotherapy alone. …

Matched conditions: ORAL CAVITY MUCOSAL MELANOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 18, 2026 14:55 UTC

ORAL CAVITY MUCOSAL MELANOMA

Get alerted when new ORAL CAVITY MUCOSAL MELANOMA trials appear

Double attack on rare cancer: can new drug combo stop deadly Melanoma's return?